Viatris, Inc. (VTRS)
16.70
+0.52
(+3.21%)
USD |
NASDAQ |
Jul 02, 16:00
16.60
-0.10
(-0.60%)
After-Hours: 20:00
Viatris Market Cap : 19.45B for July 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 02, 2026 | 19.45B |
| July 01, 2026 | 18.84B |
| June 30, 2026 | 18.49B |
| June 29, 2026 | 18.90B |
| June 26, 2026 | 19.02B |
| June 25, 2026 | 18.71B |
| June 24, 2026 | 18.55B |
| June 23, 2026 | 18.34B |
| June 22, 2026 | 17.91B |
| June 18, 2026 | 17.90B |
| June 17, 2026 | 18.32B |
| June 16, 2026 | 18.68B |
| June 15, 2026 | 19.00B |
| June 12, 2026 | 19.19B |
| June 11, 2026 | 18.99B |
| June 10, 2026 | 18.36B |
| June 09, 2026 | 18.86B |
| June 08, 2026 | 18.55B |
| June 05, 2026 | 18.49B |
| June 04, 2026 | 18.51B |
| June 03, 2026 | 18.12B |
| June 02, 2026 | 18.27B |
| June 01, 2026 | 18.41B |
| May 29, 2026 | 18.93B |
| May 28, 2026 | 18.76B |
| Date | Value |
|---|---|
| May 27, 2026 | 18.97B |
| May 26, 2026 | 18.94B |
| May 22, 2026 | 19.39B |
| May 21, 2026 | 19.17B |
| May 20, 2026 | 19.32B |
| May 19, 2026 | 18.83B |
| May 18, 2026 | 19.22B |
| May 15, 2026 | 19.19B |
| May 14, 2026 | 20.10B |
| May 13, 2026 | 20.23B |
| May 12, 2026 | 20.00B |
| May 11, 2026 | 19.70B |
| May 08, 2026 | 20.00B |
| May 07, 2026 | 20.25B |
| May 06, 2026 | 18.57B |
| May 05, 2026 | 18.07B |
| May 04, 2026 | 17.70B |
| May 01, 2026 | 17.51B |
| April 30, 2026 | 17.40B |
| April 29, 2026 | 17.43B |
| April 28, 2026 | 17.26B |
| April 27, 2026 | 17.25B |
| April 24, 2026 | 16.99B |
| April 23, 2026 | 17.18B |
| April 22, 2026 | 16.91B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 138.60B |
| Merck & Co., Inc. | 319.97B |
| Teva Pharmaceutical Industries Ltd. | 40.32B |
| Bristol Myers Squibb Co. | 118.70B |
| Amneal Pharmaceuticals, Inc. | 5.471B |
Market Cap Related Metrics
| PS Ratio | 1.337 |
| Price to Book Value | 1.327 |
| Price to Free Cash Flow | 11.85 |
| Price | 16.70 |
| Earnings Yield | -1.55% |
| Operating PE Ratio | 14.85 |
| Normalized PE Ratio | 53.91 |